Literature DB >> 201040

The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms.

M K Browne, G B Leslie, R W Pfirrman, H Brodhage.   

Abstract

An antibacterial agent, taurolin, formed by the combination of 2 molecules of taurine with 3 molecules of formaldehyde has been tested against anaerobes in vitro and in vivo. In vitro, taurolin is highly active against Bacteroides species and anaerobic Streptococci as measured by the minimum inhibitory concentration. In vivo, small dosages of taurolin given intraperitoneally increase the mortality in mice with Bacteroides peritonitis. However, by increasing the dosage of taurolin, survival is prolonged and mortality reduced. Intravenously administered taurolin protects rabbits from the effects of Bacteroides fragilis infection whether the organisms are given intravenously or intraperitoneally.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201040

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  8 in total

1.  The characterisation and quantitation by high-performance liquid chromatography of the metabolites of taurolin.

Authors:  B I Knight; G G Skellern; M K Browne; R W Pfirrmann
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

2.  [In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity].

Authors:  L Petrovic; K A Schlegel; J Ries; J Park; E Diebel; S Schultze-Mosgau; J Wiltfang
Journal:  Mund Kiefer Gesichtschir       Date:  2003-02-14

3.  The Antiseptic and Antineoplastic Agent Taurolidine Modulates Key Leukocyte Functions.

Authors:  Yannick Wouters; Gina R H Mennen; René H M Te Morsche; Hennie M J Roelofs; Geert J A Wanten
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

4.  Peritoneal absorption of the antibacterial and antiendotoxin taurolin in peritonitis.

Authors:  B I Knight; G G Skellern; M K Browne; R W Pfirrmann
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

5.  [Effects and side effects of taurolin in experimental peritonitis in the rat].

Authors:  H Hart; J Seifert; W Brendel
Journal:  Langenbecks Arch Chir       Date:  1986

6.  Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.

Authors:  Ruediger Stendel; Louis Scheurer; Kathrin Schlatterer; Urs Stalder; Rolf W Pfirrmann; Ingo Fiss; Hanns Möhler; Laurent Bigler
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

7.  [Therapy of purulent peritonitis. Documentation of 78 cases and experience with taurolin (author's transl)].

Authors:  M M Linder; W Ott; G Wesch; O Wicki; M C Marti; G Moser
Journal:  Langenbecks Arch Chir       Date:  1981

8.  Efficacy of Taurolidine Irrigation in Primary Total Knee Arthroplasty.

Authors:  Young Ha Woo; Ju Seon Jeong; Ok Geol Kim; In Seung Lee
Journal:  Knee Surg Relat Res       Date:  2018-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.